← Back to Procter & Gamble Health Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
PGHLPharmaceuticals

Procter & Gamble Health Ltd — Profit & Loss Statement

₹4798.80
-1.61%

Procter & Gamble Health Ltd Profit & Loss Statement (Annual)

Metric2024202320222021
Tax Effect Of Unusual Items-5.34 Cr0.37 Cr-0.18 Cr-1.30 Cr
Tax Rate For Calcs0.260.260.240.25
Normalized EBITDA322.14 Cr341.63 Cr281.60 Cr269.29 Cr
Total Unusual Items-20.70 Cr1.44 Cr-0.73 Cr-5.17 Cr
Total Unusual Items Excluding Goodwill-20.70 Cr1.44 Cr-0.73 Cr-5.17 Cr
Net Income From Continuing Operation Net Minority Interest200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Reconciled Depreciation27.40 Cr28.10 Cr27.08 Cr30.04 Cr
Reconciled Cost Of Revenue359.49 Cr392.13 Cr339.80 Cr336.57 Cr
EBITDA301.44 Cr343.07 Cr280.87 Cr264.12 Cr
EBIT274.04 Cr314.97 Cr253.79 Cr234.08 Cr
Net Interest Income11.01 Cr13.56 Cr-0.42 Cr14.26 Cr
Interest Expense0.72 Cr0.77 Cr0.42 Cr0.80 Cr
Interest Income11.73 Cr14.33 Cr11.07 Cr15.06 Cr
Normalized Income216.34 Cr228.40 Cr193.07 Cr180.67 Cr
Net Income From Continuing And Discontinued Operation200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Total Expenses850.38 Cr910.01 Cr873.08 Cr765.71 Cr
Rent Expense Supplemental0.37 Cr0.47 Cr0.56 Cr1.05 Cr
Diluted Average Shares1.66 Cr1.66 Cr1.66 Cr1.66 Cr
Basic Average Shares1.66 Cr1.66 Cr1.66 Cr1.66 Cr
Diluted EPS121.00138.00115.98107.00
Basic EPS121.00138.00115.98107.00
Diluted NI Availto Com Stockholders200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Net Income Common Stockholders200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Net Income Including Noncontrolling Interests200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Net Income Discontinuous Operations0.000.00——
Net Income Continuous Operations200.98 Cr229.47 Cr192.52 Cr176.80 Cr
Tax Provision72.34 Cr84.73 Cr60.85 Cr56.48 Cr
Pretax Income273.32 Cr314.20 Cr253.37 Cr233.28 Cr
Other Non Operating Income Expenses3.63 Cr3.01 Cr13.19 Cr18.10 Cr
Special Income Charges-20.70 Cr1.44 Cr-0.73 Cr-5.17 Cr
Other Special Charges20.70 Cr-0.71 Cr0.54 Cr0.42 Cr
Write Off0.00-0.73 Cr0.73 Cr4.75 Cr
Impairment Of Capital Assets0.00-0.73 Cr0.73 Cr0.00
Net Non Operating Interest Income Expense11.01 Cr13.56 Cr-0.42 Cr14.26 Cr
Interest Expense Non Operating0.72 Cr0.77 Cr0.42 Cr0.80 Cr
Interest Income Non Operating11.73 Cr14.33 Cr11.07 Cr15.06 Cr
Operating Income279.11 Cr295.85 Cr241.33 Cr225.08 Cr
Operating Expense490.89 Cr517.88 Cr533.28 Cr429.14 Cr
Other Operating Expenses177.57 Cr201.45 Cr338.64 Cr144.40 Cr
Depreciation And Amortization In Income Statement27.40 Cr28.10 Cr27.08 Cr30.04 Cr
Depreciation Income Statement27.40 Cr28.10 Cr27.08 Cr30.04 Cr
Research And Development3.86 Cr5.71 Cr6.55 Cr3.93 Cr
Selling General And Administration87.63 Cr99.07 Cr132.77 Cr116.76 Cr
Selling And Marketing Expense52.65 Cr74.49 Cr109.45 Cr87.41 Cr
General And Administrative Expense34.98 Cr24.58 Cr23.32 Cr29.35 Cr
Rent And Landing Fees0.37 Cr0.47 Cr0.56 Cr1.05 Cr
Gross Profit770.00 Cr813.73 Cr774.61 Cr654.22 Cr
Cost Of Revenue359.49 Cr392.13 Cr339.80 Cr336.57 Cr
Total Revenue1.13K Cr1.21K Cr1.11K Cr990.79 Cr
Operating Revenue1.13K Cr1.21K Cr1.11K Cr990.79 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Procter & Gamble Health Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.